SBF2 Gene CMT4B2 NGS Genetic DNA Test
Introduction to the SBF2 Gene CMT4B2 NGS Genetic DNA Test
The SBF2 Gene CMT4B2 NGS Genetic DNA Test is a cutting-edge diagnostic tool utilized to identify mutations in the SBF2 gene associated with Charcot-Marie-Tooth disease type 4B2 (CMT4B2). This test employs Next Generation Sequencing (NGS) technology, which enables comprehensive analysis of genetic material, ensuring accurate detection of potential genetic disorders.
What the Test Measures
This test specifically measures the presence of mutations in the SBF2 gene, which plays a crucial role in the nervous system’s function. By analyzing the genetic code, the test can confirm or rule out hereditary neuropathies.
Who Should Consider This Test?
Individuals who exhibit symptoms of Charcot-Marie-Tooth disease, such as muscle weakness, sensory loss, or foot deformities, should consider this test. Additionally, those with a family history of neurological disorders may benefit from understanding their genetic risk factors.
Benefits of Taking the Test
- Provides clarity on genetic predispositions to neurological disorders.
- Guides treatment decisions and management plans for affected individuals.
- Offers peace of mind for patients and families through informed decision-making.
Understanding Your Results
Results from the SBF2 Gene CMT4B2 NGS Genetic DNA Test will be provided in a detailed report. It is essential to discuss these results with a qualified healthcare provider, such as a neurologist or genetic counselor, to understand their implications fully.
Test Pricing
Test Name | Discount Price | Regular Price |
---|---|---|
SBF2 Gene CMT4B2 NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
How to Book the Test
To schedule your SBF2 Gene CMT4B2 NGS Genetic DNA Test, please contact us at +2348077798758 or visit our website to book your appointment today. Ensure you provide a clinical history and consider a genetic counseling session to discuss family history related to the SBF2 Gene CMT4B2.
Turnaround time for the test results is approximately 3 to 4 weeks. Sample types accepted include blood, extracted DNA, or one drop of blood on an FTA card.